New molecular targets for chronic C1–C2 (atlanto‑axial) neck pain

Identifying novel therapeutic targets for chronic neck pain: RNA-sequencing in human painful atlanto-axial arthropathy

['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-11173593

Using tissue removed during neck surgery to look for molecular signals that could lead to better treatments for people with chronic neck pain from the atlanto‑axial joint.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF WASHINGTON (nih funded)
Locations1 site (SEATTLE, UNITED STATES)
Trial IDNIH-11173593 on ClinicalTrials.gov

What this research studies

If you have chronic neck pain from arthritis of the atlanto‑axial joint and are having surgery, researchers will collect joint and nerve (dorsal root ganglion) tissue that is already being removed during the operation. They will compare those samples with tissues from people having surgery for acute fractures and with an existing database of dorsal root ganglia from people without pain. The team will run RNA sequencing to measure which genes are switched on or off and use computational methods plus detailed patient symptom information to identify molecular drivers of pain. The goal is to pinpoint biological targets that could be used to develop more specific treatments for chronic neck pain.

Who could benefit from this research

Good fit: Adults scheduled for surgery on the atlanto‑axial joint for chronic neck pain, and patients undergoing similar surgery for acute fracture who can serve as comparison participants, are the ideal candidates.

Not a fit: People whose neck pain is not due to atlanto‑axial arthritis or who are not undergoing surgery on that joint are unlikely to be eligible or directly helped by this study.

Why it matters

Potential benefit: This work could reveal new biological targets for therapies that relieve chronic neck pain and reduce reliance on opioids.

How similar studies have performed: Gene expression (RNA‑sequencing) studies have revealed pain‑related signals in other tissues, but applying RNA‑seq to human atlanto‑axial joint and associated dorsal root ganglia is relatively new.

Where this research is happening

SEATTLE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.